The effect of nicorandil on small intestinal ischemia-reperfusion injury in a canine model

Digestive Diseases and Sciences

Volumn 56, Issue 8, 2011, Pages 2276-2282

  Suto, Yujin ^a   Oshima, Kiyohiro ^a   Arakawa, Kazuhisa ^a   Sato, Hiroaki ^a   Yamazaki, Hodaka ^a   Matsumoto, Koshi ^b   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CML Pathological Research   (Japan)

Author keywords

Glibenclamide; Ischemia reperfusion injury; KATP channel opener; Nicorandil; Small intestine

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; NICORANDIL; NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLIP; CONTINUOUS INFUSION; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; INTESTINE BLOOD FLOW; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; INTESTINE PERFUSION; MALE; NONHUMAN; PH; PRIORITY JOURNAL; REPERFUSION INJURY; SMALL INTESTINE MUCOSA; STOMACH MUCOSA LESION; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; FEMALE; GLYBURIDE; INTESTINE, SMALL; KATP CHANNELS; MALE; MESENTERIC ARTERIES; NICORANDIL; REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 79960931488     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1623-0     Document Type: Article

References (32)

1. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94:1133-1138. (Pubitemid 32506143)
2. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol. 1992;20:765-771.
3. Takeyoshi I, Iwanami K, Ohwada S, et al. Effect of FR167653 on small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci. 1990;44:2334-2343.
4. Arakawa K, Takeyoshi I, Akao Y, et al. Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci. 2005;50:27-36. (Pubitemid 40379136)
5. Kawata K, Takeyoshi I, Iwanami K, et al. A spontaneous nitric oxide donor ameliorates small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci. 2001;46:1748-1756. (Pubitemid 32727109)
6. Sato H, Oshima K, Arakawa K, et al. Direct hemoperfusion with a polymyxin B-immobilized cartridge in intestinal warm ischemia reperfusion. World J Gastroenterol. 2008;14:5436-5441.
7. Kim JH, Jeong MH, Yun KH, Kang DK, Hong SN. Myocardial protective effects on nicorandil during percutaneous coronary intervention inpatients with unstable angina. Circ J. 2004;69:306-310.
8. Lim SY, Bae EH, Jong MH, et al. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circ J. 2004;68:928-932. (Pubitemid 39419487)
9. ATP channel. Clin Chim Acta. 2006;374:100-105.
10. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 1997;75:309-315.
11. Cavero I, Mondot S, Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther. 1989;248:1261-1268. (Pubitemid 19100782)
12. Eltze M. Glibenclamide is a competitive antagonist of cromakalim, pinacidil, and RP49356 in guinea-pig pulmonary artery. Eur J Pharmacol. 1989;165:231-239. (Pubitemid 19181791)
13. Iwanami K, Takeyoshi I, Ohwada S, et al. Intramucosal pH and intestinal mucosal damage in ischemia-reperfusion injury. Transpl Int. 1998;11:401-407. (Pubitemid 28554594)
14. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestional mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970;101:478-483.
15. Koksoy C, Kazu MA, Kazu I, et al. Role of tumor in lung injury caused by intestinal ischemia-reperfusion. Br J Surg. 2001;88:464-468.
16. Koike K, Moore FA, Moore EE, et al. Gut ischemia mediates lung injury by a xasnthine oxidase-dependent neutrophil mechanism. J Surg Res. 1993;54:469-473. (Pubitemid 23286824)
17. Wolfard A, Vangel R, Szalay L, et al. Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion. Transplantation. 1999;68:1231-1238.
18. Takahashi T, Kunimoto F, Ichikawa H, et al. Gastric intramucosal pH and hepatic venous oximetry after cardiopulmonary bypass in valve replacement patients. Cardiovasc Surg. 1996;4:308-310. (Pubitemid 26186272)
19. Yamazaki H, Oshima K, Sato H, et al. The effect of nicorandil on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model. J Surg Res. 2009 Oct 22. [Epub ahead of print].
20. Lee TM, Lin MS, Chang NC. Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J Am Coll Cardiol. 2008;51:1309-1318.
21. Nakae I, Quan L, Hashimoto K, et al. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs. Cardiovasc Drugs Ther. 1994;8:137-145. (Pubitemid 24164811)
22. ATP channels and an overview of alternative mechanisms. J Mol Cell Cardiol. 2005;39:17-50.
23. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136. (Pubitemid 17174962)
24. 2+ overload with accompanying depolarization of the mitochondrial membrane in the heart. Naunyn-Schmiedeberg's Arch Pharmacol. 2004;369:192-197.
25. Miura T, Liu Y, Kita H, Ogawa T, Shimamoto K. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol. 2000;35:238-245. (Pubitemid 30061286)
26. Davie CS, Kubo M, Standen NB. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries. Br J Pharmacol. 1998;125:1715-1725. (Pubitemid 29000818)
27. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18-24.
28. Geshi E, Ishioka H, Nomizo A, Nakatani M, Katagiri T. Biochemical and ultrastructural evaluations of the effect of ischemic preconditioning on ischemic myocardial injury. Jpn Circ J. 1998;62:915-924.
29. Hashimoto K, Kinoshita M, Ohbayashi Y. Coronary effect of nicorandil in comparison with nitroglycerin in chronic conscious dogs. Cardiovasc Drug Ther. 1991;5:131-138.
30. Minamiyama Y, Takemura S, Hai S, Suehiro S, Okada S, Funae Y. Nicorandil elevates tissue cGMP levels in a nitric-oxidein-dependent manner. J Pharmacol Sci. 2007;103:33-39. (Pubitemid 46175593)
31. Kang CS, Chen CC, Lin CC, Chang NC, Lee TM. Effect of ATP-sensitive potassium channel agonist on sympathetic hyperinnervation in postinfarcted rat hearts. Am J Physiol Heart Circ Physiol. 2009;296:H1949-H1959.
32. Del Valle HF, Lascano EC, Negroni JA, Crottogini AJ. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc Res. 2001;50:474-485. (Pubitemid 32480241)e